WealthSource Partners’s Elevance Health ELV Stock Holding History

WealthSource Partners’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-465	Closed	-$211K	–	495
2022 Q3	$211K	Buy	+465	New	+$222K	0.02%	454
2022 Q2	–	Sell	-455	Closed	-$224K	–	538
2022 Q1	$224K	Sell	455 -176	-28%	-$80.5K	0.02%	522
2021 Q4	$293K	Sell	631 -37	-6%	-$15.6K	0.02%	440
2021 Q3	$249K	Buy	668 +2	+0.3%	+$760	0.02%	439
2021 Q2	$254K	Buy	+666	New	+$255K	0.02%	399
2019 Q4	–	Sell	-2,368	Closed	-$569K	–	423
2019 Q3	$569K	Buy	2,368 +732	+45%	+$201K	0.09%	215
2019 Q2	$462K	Buy	+1,636	New	+$447K	0.07%	254
2016 Q3	–	Sell	-2,160	Closed	-$284K	–	271
2016 Q2	$284K	Sell	2,160 -98	-4%	-$13.4K	0.11%	179
2016 Q1	$314K	Buy	+2,258	New	+$302K	0.13%	156

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

WealthSource Partners's ELV Position: Q4 2022 in Review

WealthSource Partners sold out of Elevance Health (ELV) in Q4 2022, closing a stake of 465 shares — an estimated $211K sold.

WealthSource Partners first reported a position in ELV in Q1 2016 and held it in 9 quarters. The position peaked at $569K in Q3 2019. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

WealthSource Partners reported no remaining Elevance Health position as of Q4 2022 after selling out during the quarter.
WealthSource Partners sold 465 Elevance Health shares in Q4 2022, an estimated $211K.
WealthSource Partners first reported a position in Elevance Health in Q1 2016 and held it in 9 quarters.
WealthSource Partners's Elevance Health position peaked at $569K in Q3 2019.
1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on WealthSource Partners's 13F filing for Q4 2022, filed 10 Feb 2023.